Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 270 entries
Sorted by: Best Match Show Resources per page
Effects of Isoniazid on Tolerance and Sensitization to the Rewarding Properties of Morphine: A Conditioned Place Preference Procedure Investigation in Mice.

Basic and clinical neuroscience

Barzegari AA, Shahabi K.
PMID: 33613886
Basic Clin Neurosci. 2020 Jul-Aug;11(4):481-490. doi: 10.32598/bcn.11.4.1940.1. Epub 2020 Jul 01.

INTRODUCTION: The GABAergic system of the brain plays a key role in morphine tolerance and sensitization. As isoniazid is a modulator of the GABAergic system, the present study aims to understand whether isoniazid can influence the induction of tolerance...

Cite
Barzegari AA, Shahabi K. Effects of Isoniazid on Tolerance and Sensitization to the Rewarding Properties of Morphine: A Conditioned Place Preference Procedure Investigation in Mice. Basic Clin Neurosci. 2020;11(4):481-490doi: 10.32598/bcn.11.4.1940.1.
Barzegari, A. A., & Shahabi, K. (2020). Effects of Isoniazid on Tolerance and Sensitization to the Rewarding Properties of Morphine: A Conditioned Place Preference Procedure Investigation in Mice. Basic and clinical neuroscience, 11(4), 481-490. https://doi.org/10.32598/bcn.11.4.1940.1
Barzegari, Amir Abbas, and Shahabi, Kamran. "Effects of Isoniazid on Tolerance and Sensitization to the Rewarding Properties of Morphine: A Conditioned Place Preference Procedure Investigation in Mice." Basic and clinical neuroscience vol. 11,4 (2020): 481-490. doi: https://doi.org/10.32598/bcn.11.4.1940.1
Barzegari AA, Shahabi K. Effects of Isoniazid on Tolerance and Sensitization to the Rewarding Properties of Morphine: A Conditioned Place Preference Procedure Investigation in Mice. Basic Clin Neurosci. 2020 Jul-Aug;11(4):481-490. doi: 10.32598/bcn.11.4.1940.1. Epub 2020 Jul 01. PMID: 33613886; PMCID: PMC7878033.
Copy Download .nbib Format: NLM
The relationship between COVID-19 viral load and disease severity: A systematic review.

Immunity, inflammation and disease

Dadras O, Afsahi AM, Pashaei Z, Mojdeganlou H, Karimi A, Habibi P, Barzegary A, Fakhfouri A, Mirzapour P, Janfaza N, Dehghani S, Afroughi F, Dashti M, Khodaei S, Mehraeen E, Voltarelli F, Sabatier JM, SeyedAlinaghi S.
PMID: 34904379
Immun Inflamm Dis. 2021 Dec 13; doi: 10.1002/iid3.580. Epub 2021 Dec 13.

INTRODUCTION: Patients with COVID-19 may present different viral loads levels. However, the relationship between viral load and disease severity in COVID-19 is still unknown. Therefore, this study aimed to systematically review the association between SARS-CoV-2 viral load and COVID-19...

Cite
Dadras O, Afsahi AM, Pashaei Z, et al. The relationship between COVID-19 viral load and disease severity: A systematic review. Immun Inflamm Dis. 2021;doi: 10.1002/iid3.580.
Dadras, O., Afsahi, A. M., Pashaei, Z., Mojdeganlou, H., Karimi, A., Habibi, P., Barzegary, A., Fakhfouri, A., Mirzapour, P., Janfaza, N., Dehghani, S., Afroughi, F., Dashti, M., Khodaei, S., Mehraeen, E., Voltarelli, F., Sabatier, J. M., & SeyedAlinaghi, S. (2021). The relationship between COVID-19 viral load and disease severity: A systematic review. Immunity, inflammation and disease, . https://doi.org/10.1002/iid3.580
Dadras, Omid, et al. "The relationship between COVID-19 viral load and disease severity: A systematic review." Immunity, inflammation and disease vol. (2021). doi: https://doi.org/10.1002/iid3.580
Dadras O, Afsahi AM, Pashaei Z, Mojdeganlou H, Karimi A, Habibi P, Barzegary A, Fakhfouri A, Mirzapour P, Janfaza N, Dehghani S, Afroughi F, Dashti M, Khodaei S, Mehraeen E, Voltarelli F, Sabatier JM, SeyedAlinaghi S. The relationship between COVID-19 viral load and disease severity: A systematic review. Immun Inflamm Dis. 2021 Dec 13; doi: 10.1002/iid3.580. Epub 2021 Dec 13. PMID: 34904379.
Copy Download .nbib Format: NLM
Packet Flow Capacity Autonomous Operation Based on Reinforcement Learning.

Sensors (Basel, Switzerland)

Barzegar S, Ruiz M, Velasco L.
PMID: 34960400
Sensors (Basel). 2021 Dec 12;21(24). doi: 10.3390/s21248306.

As the dynamicity of the traffic increases, the need for self-network operation becomes more evident. One of the solutions that might bring cost savings to network operators is the dynamic capacity management of large packet flows, especially in the...

Cite
Barzegar S, Ruiz M, Velasco L. Packet Flow Capacity Autonomous Operation Based on Reinforcement Learning. Sensors (Basel). 2021;21(24)doi: 10.3390/s21248306.
Barzegar, S., Ruiz, M., & Velasco, L. (2021). Packet Flow Capacity Autonomous Operation Based on Reinforcement Learning. Sensors (Basel, Switzerland), 21(24), . https://doi.org/10.3390/s21248306
Barzegar, Sima, et al. "Packet Flow Capacity Autonomous Operation Based on Reinforcement Learning." Sensors (Basel, Switzerland) vol. 21,24 (2021). doi: https://doi.org/10.3390/s21248306
Barzegar S, Ruiz M, Velasco L. Packet Flow Capacity Autonomous Operation Based on Reinforcement Learning. Sensors (Basel). 2021 Dec 12;21(24). doi: 10.3390/s21248306. PMID: 34960400.
Copy Download .nbib Format: NLM
Intravenous furosemide vs nebulized furosemide in patients with pulmonary edema: A randomized controlled trial.

Health science reports

Barzegari H, Khavanin A, Delirrooyfard A, Shaabani S.
PMID: 33490638
Health Sci Rep. 2021 Jan 14;4(1):e235. doi: 10.1002/hsr2.235. eCollection 2021 Mar.

BACKGROUND AND AIMS: Pulmonary edema is one of the most common acute respiratory disorders that diagnosis and treatment of the disease still remain as a health problem. The aim of this study was to compare the efficacy of intravenous...

Cite
Barzegari H, Khavanin A, Delirrooyfard A, et al. Intravenous furosemide vs nebulized furosemide in patients with pulmonary edema: A randomized controlled trial. Health Sci Rep. 2021;4(1):e235doi: 10.1002/hsr2.235.
Barzegari, H., Khavanin, A., Delirrooyfard, A., & Shaabani, S. (2021). Intravenous furosemide vs nebulized furosemide in patients with pulmonary edema: A randomized controlled trial. Health science reports, 4(1), e235. https://doi.org/10.1002/hsr2.235
Barzegari, Hasan, et al. "Intravenous furosemide vs nebulized furosemide in patients with pulmonary edema: A randomized controlled trial." Health science reports vol. 4,1 (2021): e235. doi: https://doi.org/10.1002/hsr2.235
Barzegari H, Khavanin A, Delirrooyfard A, Shaabani S. Intravenous furosemide vs nebulized furosemide in patients with pulmonary edema: A randomized controlled trial. Health Sci Rep. 2021 Jan 14;4(1):e235. doi: 10.1002/hsr2.235. eCollection 2021 Mar. PMID: 33490638; PMCID: PMC7808786.
Copy Download .nbib Format: NLM
Validity, Reliability, and Optimal Cut-off Scores of the WHO-5, PHQ-9, and PHQ-2 to Screen Depression Among University Students in Iran.

International journal of mental health and addiction

Ghazisaeedi M, Mahmoodi H, Arpaci I, Mehrdar S, Barzegari S.
PMID: 33495691
Int J Ment Health Addict. 2021 Jan 20;1-10. doi: 10.1007/s11469-021-00483-5. Epub 2021 Jan 20.

This study aimed to investigate the validity, reliability, and optimal cut-off points for the Patient Health Questionnaire-2 (PHQ-2), Patient Health Questionnaire-9 (PHQ-9), and Well-being Index (WHO-5) to screen mild depression among 400 Iranian students who completed these tools and...

Cite
Ghazisaeedi M, Mahmoodi H, Arpaci I, et al. Validity, Reliability, and Optimal Cut-off Scores of the WHO-5, PHQ-9, and PHQ-2 to Screen Depression Among University Students in Iran. Int J Ment Health Addict. 2021;1-10doi: 10.1007/s11469-021-00483-5.
Ghazisaeedi, M., Mahmoodi, H., Arpaci, I., Mehrdar, S., & Barzegari, S. (2021). Validity, Reliability, and Optimal Cut-off Scores of the WHO-5, PHQ-9, and PHQ-2 to Screen Depression Among University Students in Iran. International journal of mental health and addiction, 1-10. https://doi.org/10.1007/s11469-021-00483-5
Ghazisaeedi, Marjan, et al. "Validity, Reliability, and Optimal Cut-off Scores of the WHO-5, PHQ-9, and PHQ-2 to Screen Depression Among University Students in Iran." International journal of mental health and addiction vol. (2021): 1-10. doi: https://doi.org/10.1007/s11469-021-00483-5
Ghazisaeedi M, Mahmoodi H, Arpaci I, Mehrdar S, Barzegari S. Validity, Reliability, and Optimal Cut-off Scores of the WHO-5, PHQ-9, and PHQ-2 to Screen Depression Among University Students in Iran. Int J Ment Health Addict. 2021 Jan 20;1-10. doi: 10.1007/s11469-021-00483-5. Epub 2021 Jan 20. PMID: 33495691; PMCID: PMC7817067.
Copy Download .nbib Format: NLM
Designing a light-activated recombinant alpha hemolysin for colorectal cancer targeting.

BioImpacts : BI

Alizadeh S, Barzegari A, Esmaeili A, Omidi Y.
PMID: 32793441
Bioimpacts. 2020;10(3):187-193. doi: 10.34172/bi.2020.23. Epub 2019 Nov 02.

No abstract available.

Cite
Alizadeh S, Barzegari A, Esmaeili A, et al. Designing a light-activated recombinant alpha hemolysin for colorectal cancer targeting. Bioimpacts. 2019;10(3):187-193doi: 10.34172/bi.2020.23.
Alizadeh, S., Barzegari, A., Esmaeili, A., & Omidi, Y. (2020). Designing a light-activated recombinant alpha hemolysin for colorectal cancer targeting. BioImpacts : BI, 10(3), 187-193. https://doi.org/10.34172/bi.2020.23
Alizadeh, Siamak, et al. "Designing a light-activated recombinant alpha hemolysin for colorectal cancer targeting." BioImpacts : BI vol. 10,3 (2020): 187-193. doi: https://doi.org/10.34172/bi.2020.23
Alizadeh S, Barzegari A, Esmaeili A, Omidi Y. Designing a light-activated recombinant alpha hemolysin for colorectal cancer targeting. Bioimpacts. 2020;10(3):187-193. doi: 10.34172/bi.2020.23. Epub 2019 Nov 02. PMID: 32793441; PMCID: PMC7416006.
Copy Download .nbib Format: NLM
Classification of seed members of five riboswitch families as short sequences based on the features extracted by Block Location-Based Feature Extraction (BLBFE) method.

BioImpacts : BI

Golabi F, Mehdizadeh Aghdam E, Shamsi M, Sedaaghi MH, Barzegar A, Hejazi MS.
PMID: 33842280
Bioimpacts. 2021;11(2):101-109. doi: 10.34172/bi.2021.17. Epub 2020 Apr 17.

No abstract available.

Cite
Golabi F, Mehdizadeh Aghdam E, Shamsi M, et al. Classification of seed members of five riboswitch families as short sequences based on the features extracted by Block Location-Based Feature Extraction (BLBFE) method. Bioimpacts. 2020;11(2):101-109doi: 10.34172/bi.2021.17.
Golabi, F., Mehdizadeh Aghdam, E., Shamsi, M., Sedaaghi, M. H., Barzegar, A., & Hejazi, M. S. (2021). Classification of seed members of five riboswitch families as short sequences based on the features extracted by Block Location-Based Feature Extraction (BLBFE) method. BioImpacts : BI, 11(2), 101-109. https://doi.org/10.34172/bi.2021.17
Golabi, Faegheh, et al. "Classification of seed members of five riboswitch families as short sequences based on the features extracted by Block Location-Based Feature Extraction (BLBFE) method." BioImpacts : BI vol. 11,2 (2021): 101-109. doi: https://doi.org/10.34172/bi.2021.17
Golabi F, Mehdizadeh Aghdam E, Shamsi M, Sedaaghi MH, Barzegar A, Hejazi MS. Classification of seed members of five riboswitch families as short sequences based on the features extracted by Block Location-Based Feature Extraction (BLBFE) method. Bioimpacts. 2021;11(2):101-109. doi: 10.34172/bi.2021.17. Epub 2020 Apr 17. PMID: 33842280; PMCID: PMC8022236.
Copy Download .nbib Format: NLM
Rational design of a new variant of Reteplase with optimized physicochemical profile and large-scale production in Escherichia coli.

World journal of microbiology & biotechnology

Seyedhosseini Ghaheh H, Sajjadi S, Shafiee F, Barzegari E, Moazen F, Mir Mohammad Sadeghi H.
PMID: 34989886
World J Microbiol Biotechnol. 2022 Jan 06;38(2):29. doi: 10.1007/s11274-021-03204-1.

Structural engineering of the recombinant thrombolytic drug, Reteplase, and its cost-effective production are important goals in the pharmaceutical industry. In this study, a single-point mutant of the protein was rationally designed and evaluated in terms of physicochemical characteristics, enzymatic...

Cite
Seyedhosseini Ghaheh H, Sajjadi S, Shafiee F, et al. Rational design of a new variant of Reteplase with optimized physicochemical profile and large-scale production in Escherichia coli. World J Microbiol Biotechnol. 2022;38(2):29doi: 10.1007/s11274-021-03204-1.
Seyedhosseini Ghaheh, H., Sajjadi, S., Shafiee, F., Barzegari, E., Moazen, F., & Mir Mohammad Sadeghi, H. (2022). Rational design of a new variant of Reteplase with optimized physicochemical profile and large-scale production in Escherichia coli. World journal of microbiology & biotechnology, 38(2), 29. https://doi.org/10.1007/s11274-021-03204-1
Seyedhosseini Ghaheh, Hooria, et al. "Rational design of a new variant of Reteplase with optimized physicochemical profile and large-scale production in Escherichia coli." World journal of microbiology & biotechnology vol. 38,2 (2022): 29. doi: https://doi.org/10.1007/s11274-021-03204-1
Seyedhosseini Ghaheh H, Sajjadi S, Shafiee F, Barzegari E, Moazen F, Mir Mohammad Sadeghi H. Rational design of a new variant of Reteplase with optimized physicochemical profile and large-scale production in Escherichia coli. World J Microbiol Biotechnol. 2022 Jan 06;38(2):29. doi: 10.1007/s11274-021-03204-1. PMID: 34989886.
Copy Download .nbib Format: NLM
Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis.

Journal of clinical medicine

Mirmosayyeb O, Brand S, Barzegar M, Afshari-Safavi A, Nehzat N, Shaygannejad V, Sadeghi Bahmani D.
PMID: 32370288
J Clin Med. 2020 May 02;9(5). doi: 10.3390/jcm9051326.

BACKGROUND: Compared to the adult onset of multiple sclerosis (AOMS), both early-onset (EOMS) and late-onset (LOMS) are much less frequent, but are often under- or misdiagnosed. The aims of the present study were: 1. To compare demographic and clinical...

Cite
Mirmosayyeb O, Brand S, Barzegar M, et al. Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis. J Clin Med. 2020;9(5)doi: 10.3390/jcm9051326.
Mirmosayyeb, O., Brand, S., Barzegar, M., Afshari-Safavi, A., Nehzat, N., Shaygannejad, V., & Sadeghi Bahmani, D. (2020). Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis. Journal of clinical medicine, 9(5), . https://doi.org/10.3390/jcm9051326
Mirmosayyeb, Omid, et al. "Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis." Journal of clinical medicine vol. 9,5 (2020). doi: https://doi.org/10.3390/jcm9051326
Mirmosayyeb O, Brand S, Barzegar M, Afshari-Safavi A, Nehzat N, Shaygannejad V, Sadeghi Bahmani D. Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis. J Clin Med. 2020 May 02;9(5). doi: 10.3390/jcm9051326. PMID: 32370288; PMCID: PMC7290335.
Copy Download .nbib Format: NLM
Efficacy of Custom-Made Appliance by the Method of CAD/CAM Compared with Conventional Dressing for Reducing Facial Swelling after Maxillofacial Surgery.

Journal of dentistry (Shiraz, Iran)

Faryabi J, Barzegar M, Pouradeli S.
PMID: 31875177
J Dent (Shiraz). 2019 Dec;20(4):292-297. doi: 10.30476/DENTJODS.2019.77797..

STATEMENT OF THE PROBLEM: Swelling of the surrounding tissue of surgical site is one of the most common, devastating effects after maxillofacial surgery and can have an effect on quality of life and the patients' satisfaction.PURPOSE: The purpose of...

Cite
Faryabi J, Barzegar M, Pouradeli S. Efficacy of Custom-Made Appliance by the Method of CAD/CAM Compared with Conventional Dressing for Reducing Facial Swelling after Maxillofacial Surgery. J Dent (Shiraz). 2019;20(4):292-297doi: 10.30476/DENTJODS.2019.77797..
Faryabi, J., Barzegar, M., & Pouradeli, S. (2019). Efficacy of Custom-Made Appliance by the Method of CAD/CAM Compared with Conventional Dressing for Reducing Facial Swelling after Maxillofacial Surgery. Journal of dentistry (Shiraz, Iran), 20(4), 292-297. https://doi.org/10.30476/DENTJODS.2019.77797.
Faryabi, Javad, et al. "Efficacy of Custom-Made Appliance by the Method of CAD/CAM Compared with Conventional Dressing for Reducing Facial Swelling after Maxillofacial Surgery." Journal of dentistry (Shiraz, Iran) vol. 20,4 (2019): 292-297. doi: https://doi.org/10.30476/DENTJODS.2019.77797.
Faryabi J, Barzegar M, Pouradeli S. Efficacy of Custom-Made Appliance by the Method of CAD/CAM Compared with Conventional Dressing for Reducing Facial Swelling after Maxillofacial Surgery. J Dent (Shiraz). 2019 Dec;20(4):292-297. doi: 10.30476/DENTJODS.2019.77797.. PMID: 31875177; PMCID: PMC6890810.
Copy Download .nbib Format: NLM
Association between prostate-specific antigen change over time and prostate cancer recurrence risk: A joint model.

Caspian journal of internal medicine

Ali Mohammadpour R, Alizadeh A, Barzegar MR, Akbarzadeh Pasha A.
PMID: 32874441
Caspian J Intern Med. 2020 May;11(3):324-328. doi: 10.22088/cjim.11.3.324.

BACKGROUND: Prostate specific antigen (PSA) is an important biomarker to monitor patients after treated with radiation therapy (RT). The aim of this study is to evaluate the relationship between the PSA data and prostate cancer recurrence using the joint...

Cite
Ali Mohammadpour R, Alizadeh A, Barzegar MR, et al. Association between prostate-specific antigen change over time and prostate cancer recurrence risk: A joint model. Caspian J Intern Med. 2020;11(3):324-328doi: 10.22088/cjim.11.3.324.
Ali Mohammadpour, R., Alizadeh, A., Barzegar, M. R., & Akbarzadeh Pasha, A. (2020). Association between prostate-specific antigen change over time and prostate cancer recurrence risk: A joint model. Caspian journal of internal medicine, 11(3), 324-328. https://doi.org/10.22088/cjim.11.3.324
Ali Mohammadpour, Reza, et al. "Association between prostate-specific antigen change over time and prostate cancer recurrence risk: A joint model." Caspian journal of internal medicine vol. 11,3 (2020): 324-328. doi: https://doi.org/10.22088/cjim.11.3.324
Ali Mohammadpour R, Alizadeh A, Barzegar MR, Akbarzadeh Pasha A. Association between prostate-specific antigen change over time and prostate cancer recurrence risk: A joint model. Caspian J Intern Med. 2020 May;11(3):324-328. doi: 10.22088/cjim.11.3.324. PMID: 32874441; PMCID: PMC7442453.
Copy Download .nbib Format: NLM
[No title available]

BioImpacts : BI

Maleki-Kakelar H, Dehghani J, Barzegari A, Barar J, Shirmohamadi M, Sadeghi J, Omidi Y.
PMID: 32363150
Bioimpacts. 2020;10(2):65-72. doi: 10.34172/bi.2020.09. Epub 2019 Jun 28.

No abstract available.

Cite
Maleki-Kakelar H, Dehghani J, Barzegari A, et al. . Bioimpacts. 2019;10(2):65-72doi: 10.34172/bi.2020.09.
Maleki-Kakelar, H., Dehghani, J., Barzegari, A., Barar, J., Shirmohamadi, M., Sadeghi, J., & Omidi, Y. (2020). . BioImpacts : BI, 10(2), 65-72. https://doi.org/10.34172/bi.2020.09
Maleki-Kakelar, Hadi, et al. "." BioImpacts : BI vol. 10,2 (2020): 65-72. doi: https://doi.org/10.34172/bi.2020.09
Maleki-Kakelar H, Dehghani J, Barzegari A, Barar J, Shirmohamadi M, Sadeghi J, Omidi Y. . Bioimpacts. 2020;10(2):65-72. doi: 10.34172/bi.2020.09. Epub 2019 Jun 28. PMID: 32363150; PMCID: PMC7186545.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 270 entries